Detection of pre-neoplastic and neoplastic prostate disease by MADI profiling of urine
- 22 December 2006
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 353 (3), 829-834
- https://doi.org/10.1016/j.bbrc.2006.12.111
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Unravelling in vitro variables of major importance for the outcome of mass spectrometry-based serum proteomicsJournal of Chromatography B, 2006
- Differential exoprotease activities confer tumor-specific serum peptidome patternsJCI Insight, 2005
- Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate CancerScience, 2005
- Serum Peptide Profiling by Magnetic Particle-Assisted, Automated Sample Processing and MALDI-TOF Mass SpectrometryAnalytical Chemistry, 2004
- Cancer Statistics, 2004CA: A Cancer Journal for Clinicians, 2004
- Differential protein synthesis and expression levels in normal and neoplastic human prostate cells and their regulation by type I and II interferonsOncogene, 2003
- Pathological and molecular aspects of prostate cancerThe Lancet, 2003
- PREOPERATIVE SERUM PROSTATE SPECIFIC ANTIGEN LEVELS BETWEEN 2 AND 22 NG./ML. CORRELATE POORLY WITH POST-RADICAL PROSTATECTOMY CANCER MORPHOLOGY: PROSTATE SPECIFIC ANTIGEN CURE RATES APPEAR CONSTANT BETWEEN 2 AND 9 NG./ML.Journal of Urology, 2002
- The Incidence of High Grade Prostatic Intraepithelial Neoplasia in Needle BiopsiesJournal of Urology, 1995
- Study of childhood renal tumours using a monoclonal antibody to Tamm-Horsfall protein.Journal of Clinical Pathology, 1987